Ophthalmology · Miami, FL
NPI
1942238522
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
351 NW 42nd Ave, Suite 302
Miami, FL, 33126
Phone (305) 643-8871
Groups this clinician bills Medicare through
Medicare paid, 2024
$635K
8,774 services
Medicare patients, 2024
413
Average age 78
Drug cost, 2024
$4.3M
3,939 prescriptions
Company payments, 2025
$1,596
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wilfredo C Lara was code J2777 (injection, faricimab-svoa, 0.1 mg), 3,300 times for 14 patients. In total Wilfredo C Lara billed 8,774 services in 37 codes, and Medicare paid $635K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 3,300 | 14 | $27.59 | $91K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,062 | 384 | $31.76 | $34K |
| 67028 Intravitreal Injection | Office | 1,019 | 202 | $103.60 | $106K |
| 92012 Ophthalmological E&M | Office | 946 | 220 | $71.28 | $67K |
| 92250 Angiography | Office | 612 | 376 | $29.42 | $18K |
| J7999 Compounded drug, not otherwise classified | Office | 595 | 149 | $62.52 | $37K |
| 92014 Ophthalmological E&M | Office | 308 | 248 | $92.23 | $28K |
| J0178 Injection, aflibercept, 1 mg | Office | 258 | 27 | $661.81 | $171K |
| J9999 Not otherwise classified, antineoplastic drugs | Office | 211 | 102 | $65.39 | $14K |
| J9035 Injection, bevacizumab, 10 mg | Office | 91 | 68 | $55.71 | $5,070 |
| 92004 Ophthalmological E&M | Office | 83 | 83 | $106.38 | $8,830 |
| 76512 Ultrasound - Nonspecific | Office | 63 | 43 | $51.40 | $3,238 |
| 67210 Eye | Office | 43 | 35 | $433.39 | $19K |
| 92235 Angiography | Office | 37 | 37 | $140.07 | $5,183 |
By year: 2022 $1.8M for 8,376 services; 2023 $735K for 9,044 services; 2024 $635K for 8,774 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wilfredo C Lara prescribed most often to Medicare patients was Eylea (Aflibercept), with 1,170 prescriptions and refills. In total Wilfredo C Lara wrote 3,939 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 1,170 | 1,171 | 223 | $2.6M |
| Prednisolone Acetate Generic | 932 | 1,449 | 372 | $42K |
| Ofloxacin Generic | 273 | 323 | 190 | $4,629 |
| Simbrinza Brinzolamide/Brimonidine Tart | 175 | 321 | 74 | $36K |
| Vabysmo Faricimab-Svoa | 150 | 150 | 33 | $390K |
| Syfovre Pegcetacoplan/Pf | 124 | 124 | 17 | $389K |
| Eylea Hd Aflibercept | 118 | 123 | 26 | $354K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 101 | 186 | 38 | $13K |
| Lumigan Bimatoprost | 92 | 184 | 33 | $42K |
| Latanoprost Generic | 90 | 205 | 42 | $525 |
| Ozurdex Dexamethasone | 86 | 250 | 52 | $134K |
| Timolol Maleate Generic | 64 | 123 | 24 | $385 |
| Combigan Brimonidine Tartrate/Timolol | 61 | 103 | 16 | $19K |
| Brimonidine Tartrate Generic | 59 | 120 | 24 | $6,843 |
| Difluprednate Generic | 53 | 66 | 23 | $5,049 |
Brand drugs: 3,181 claims; generic drugs: 758 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wilfredo C Lara $1,596 ($1,596 in general payments such as food, travel and fees) from 9 companies. The largest payer was Alcon Vision LLC with $593.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.